Luqa Pharma to Launch Italian Wound Healing Product in China

Luqa Pharmaceuticals, a Hong Kong in-licensing company, will begin a China launch of Ialuxid®, a non-antibiotic antimicrobial gel made by BMG Pharma S.r.l. of Italy. Ialuxid combines hyaluronic acid, hydrogen peroxide and glycine, forming a film to promote wound healing, especially surgical wounds, while fighting bacteria and inflammation. It has been approved as a medical device in Europe and China, and is under review in the US. Luqa in-licensed three products from BMG in 2013. More details.... Share this with colleagues: // //